Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Operating Expenses | 1,722 | 2,086 | 2,194 | 1,712 | 0 |
| Operating Income | -1,722 | -2,086 | -2,194 | -1,712 | N/A |
| Interest Expense | 260 | 244 | 248 | 243 | 0 |
| Other Income | -189 | -58 | -405 | -193 | 0 |
| Pre-tax Income | -2,171 | -2,388 | -2,847 | -2,148 | 0 |
| Net Income Continuous | -2,171 | -2,388 | -2,847 | -2,148 | N/A |
| Net Income | $-2,171 | $-2,388 | $-2,847 | $-2,148 | $N/A |
| EPS Basic Total Ops | -12.84 | -13.68 | -15.24 | -12.32 | N/A |
| EPS Basic Continuous Ops | -8.42 | -9.36 | -11.16 | -8.42 | N/A |
| EPS Diluted Total Ops | -12.84 | -13.68 | -15.24 | -12.32 | N/A |
| EPS Diluted Continuous Ops | -8.42 | -9.36 | -11.16 | -8.42 | N/A |
| EBITDA(a) | $-1,722 | $-2,086 | $-2,194 | $-1,712 | $N/A |